Order Article Reprints

Ersvaer E, Kittang AO, Hampson P, Sand K, Gjertsen BT, Lord JM, Bruserud Ø. The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity. Toxins. 2010; 2(1):174-194. https://doi.org/10.3390/toxins2010174

Ersvaer, Elisabeth, Astrid Olsnes Kittang, Peter Hampson, Kristoffer Sand, Bjørn Tore Gjertsen, Janet M. Lord, and Øystein Bruserud. 2010. "The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity" Toxins 2, no. 1: 174-194. https://doi.org/10.3390/toxins2010174

Ersvaer, E., Kittang, A. O., Hampson, P., Sand, K., Gjertsen, B. T., Lord, J. M., & Bruserud, Ø. (2010). The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity. Toxins, 2(1), 174-194. https://doi.org/10.3390/toxins2010174